Search alternatives:
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 026 » n 026 (Expand Search)
026 decrease » _ decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 026 » n 026 (Expand Search)
-
21
-
22
-
23
-
24
Data extracted from included studies for the systematic review and meta-analysis.
Published 2025Subjects: -
25
Specifications and outcomes of clinical trial studies included in the meta-analysis.
Published 2025Subjects: -
26
Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants
Published 2022“…A cocktail of etesevimab and JS026 increased neutralizing efficacy against both wild-type SARS-CoV-2 and the recent emergence of Alpha, Beta, Gamma, and Delta variants. …”
-
27
-
28
-
29
-
30
-
31
-
32
Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses
Published 2025“…Anthropogenic activities, particularly land use change and management practices, alter the global nitrogen (N) cycle. As a central part of the global N cycle, soil N supply from net N mineralization (NNM) and net nitrification (NN) contributes to over 50% of crop N uptake. …”
-
33
-
34
-
35
-
36
-
37
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
38
-
39
-
40
Minimal underlying data set.
Published 2024“…Decreased interleukin (IL)-23 levels in the cord blood were associated with the markedly delayed class, independent of potential confounders (odds ratio, 0.44; 95%confidence interval: 0.26–0.73). …”